Approvals/TGA/RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial

Approved

STANDARD

RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial

Approval Id: 7971ae181b0fea55
Product Name: RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Artg Id: 427684
Artg Name: RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Sponsor: UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path: /organization/ucb-australia-pty-ltd
Artg Date: 2025-02-07
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1b03835b781487686085b9f060ed4e52.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/ca424e37f8da16756945afefdf6ec3c4.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

7971ae181b0fea55

Type

Standard